The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing

Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing

December 20, 2017 • By Larry Beresford

  • Tweet
  • Email
Print-Friendly Version / Save PDF

SAN DIEGO—The 2017 ACR/ARHP Annual Meeting, Nov. 3–8, presented opportunities to highlight its 2017 legislative advocacy victories, some of which were resolved just weeks before the conference began, as well as issues that are still outstanding.

You Might Also Like
  • The American College of Rheumatology’s Legislative Successes of 2017
  • ACR’s 2017 Advocacy Successes
  • The ACR Asks Congress to Dedicate Arthritis Research Funding to Help Military Service Members
Also By This Author
  • CCL2 Cytokine Serves as Biomarker in Interstitial Lung Disease

Angus Worthing, MD, FACR, FACP

In the session, Legislative & Regulatory Update 2017, Angus Worthing, MD, chair of the ACR’s Government Advocacy Committee and an independent rheumatologist practicing in Washington, D.C., said, “A lot is happening on the advocacy front.” According to Dr. Worthing, the ACR has managed to achieve some recent successes, although one of its top priorities was to protect patients’ access to care in the face of legislative proposals to repeal the Affordable Care Act (ACA). Recent developments in D.C. suggest that some of the patient protections provided by the ACA are still in danger of repeal, if not this year, then next year.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR will continue to advance its concerns by working in coalitions with other healthcare advocates and focusing on the need to maintain access to care and treatment, taking issue with specific provisions of legislation rather than positions on overall bills, Dr. Worthing said. The priority is to ensure sufficient, affordable, continuous coverage that enlarges access to high-quality healthcare for all and the continuation of essential health benefits. In the ACR’s view, proposals to repeal the ACA have not gone far enough to protect that access, he explained.

Key Advances in 2017
Other important legislative and regulatory advances in 2017 for the field of rheumatology, highlighted in the session at the Annual Meeting, include:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

H-1B visas
At the ACR’s request, the American Medical Association’s House of Delegates passed a resolution requesting the overturn of a Trump administration proposal to stop allowing an additional fee to be charged for premium processing of H-1B visa waiver applications for physicians. The administration agreed to this request just in time for newly graduated medical fellows to make commitments to jobs in underserved areas, a critical issue for rheumatologists in particular, Dr. Worthing says.

There are only 5,000 practicing rheumatologists in the U.S., less than the current need, which is estimated at 6,115 rheumatologists, and demand is expected to exceed supply by 138% by 2030.1 “One solution to the shortage of rheumatologists is for internationally trained physicians to work in underserved areas through the H-1B visa program, but the premium processing of their applications is essential if they are to commit to jobs by the June 30 academic year deadline,” said Dr. Worthing.

Pages: 1 2 3 4 | Single Page

Filed Under: Legislation & Advocacy Tagged With: 2017 legislative successes, Cap on rehab therapy, H-1B visas, Independent Payment Advisory Board (IPAB), NIH research funding, pharmacy benefit managers (PBMs)

You Might Also Like:
  • The American College of Rheumatology’s Legislative Successes of 2017
  • ACR’s 2017 Advocacy Successes
  • The ACR Asks Congress to Dedicate Arthritis Research Funding to Help Military Service Members
  • Congress Urged to Fix CMS Rule Distorting Part B Drug Reimbursement

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)